Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ganapathy N. Sarma
Single Doses of Antibody Drug Conjugates (ADCs) Targeted to CD117 or CD45 Have Potent in Vivo Anti-Leukemia Activity and Survival Benefit in Patient Derived AML Models
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Single Doses of Antibody Drug Conjugates (ADCs) Targeted to CD117 or CD45 Have Potent in Vivo Anti-Leukemia Activity and Survival Benefit in Patient Derived AML Models
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
P2.06-08 ABT-806 Derived Antibody Drug Conjugates (ADCs) Inhibit Growth of Malignant Mesothelioma In-Vivo
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Qualitative Analysis of Antibody-Drug Conjugates (ADCs): An Experimental Comparison of Analytical Techniques of Cysteine-Linked ADCs
Analyst, The
Biochemistry
Environmental Chemistry
Analytical Chemistry
Electrochemistry
Spectroscopy
The Antitumor Activity of TCR-Mimic Antibody-Drug Conjugates (TCRm-ADCs) Targeting the Intracellular Wilms Tumor 1 (WT1) Oncoprotein
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Oligonucleotide Aptamer-Drug Conjugates for Targeted Therapy of Acute Myeloid Leukemia
Biomaterials
Mechanics of Materials
Biophysics
Biomaterials
Bioengineering
Composites
Nanoscience
Nanotechnology
Ceramics
Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
Frontiers in Pediatrics
Child Health
Pediatrics
Perinatology
Antibody-Drug Conjugates in Bladder Cancer
Bladder Cancer
Oncology
Urology
Antibody-Drug Conjugates With HER2-targeting Antibodies From Synthetic Antibody Libraries Are Highly Potent Against HER2-positive Human Gastric Tumor in Xenograft Models
mAbs
Allergy
Immunology